Effect of an Educational Intervention About Front of Package Labeling in Children and Caregivers.

NCT06102473 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 404

Last updated 2023-10-26

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effect of a digital educational intervention of front-of-package warning labeling on the selection and purchase of food in elementary school children and their caregivers.

The main question it aims to answer is:

* What is the effect of a digital educational intervention on front-of-package warning labeling on food selection in children from primary schools in Mexico City, compared to a control group? Participants will be randomized into two groups.
* The control group, the dyads (caregiver-schoolchildren), will receive general nutritional education.
* The intervention group, will also receive guidance on reading labels and raise awareness about the impact of consuming processed or ultra-processed foods on health.

The intervention will be carried out through a web page with audiovisual material and all participants also will be asked to complete:

* Multiple-choice evaluation (5 questions) to ensure theoretical understanding of the topics
* Lunch register
* 24-hour dietary recall
* Survey of food habits and consumption
* Validated food preference questionnaire
* Anthropometric measurements (Weight, height, waist circumference, body mass index)
* Socioeconomic survey
* Participate in a simulated online selection and shopping of food and beverages.

To see if the digital educational intervention in the front of package warning labeling in children and caregivers will improve the selection and purchase of foods.

Conditions

  • Overweight and Obesity
  • Malnutrition, Child

Interventions

OTHER

Nutritional education

With prior authorization from the principals of the elementary schools, meetings will be held with parents to invite them to participate, and the aim, activities, and duration of the intervention will be explained to them. They will be invited to sign a consent and informed assent, clarifying that their participation is voluntary and they may not continue at any time they wish without affecting their activities at school.

Sponsors & Collaborators

  • Diana Avila Montiel

    lead OTHER

Principal Investigators

  • Miguel Klünder-Klünder, PhD · Hospital Infantil de Mexico Federico Gomez

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2024-12-31
Completion
2025-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06102473 on ClinicalTrials.gov